Mike Stebbins
Dr. Stebbins is Senior Vice President of ATI and an accomplished executive dedicated to driving transformative outcomes in technology development and collaboration, particularly in health security, with a focus on national preparedness, response and recovery during public health emergencies and disasters. He brings extensive expertise in bridging the private sector with federal non-dilutive funding, having successfully facilitated over $12B in investments to foster innovation in the medical and health security fields. Dr. Stebbins oversees ATI’s Medical and Health Security portfolio which includes six unique Other Transaction (OT) Agreement programs for HHS and DoD valued at greater than $60B which provides funding annually of more than $1B. The HHS portfolio includes BARDA’s Rapid Response Partnership Vehicle (RRPV) and BARDA’s Biopharmaceutical Manufacturing Preparedness – Consortium (BioMaP), as well as ARPA-H’s Customer Experience Hub (CX Hub), part of the ARPANET-H Network. On the DoD side the portfolio includes the Medical Technology Enterprise Consortium (MTEC), the Medical CBRN Defense Consortium (MCDC)) and the Countering Weapons of Mass Destruction Consortium (CWMD). Dr. Stebbins has made significant contributions to national efforts, including supporting the rapid development and delivery of vaccines and treatments to address global health threats. He played a pivotal role in strengthening the U.S. industrial base and enhancing manufacturing capabilities to meet the nation’s advanced R&D and production needs. He led the creation of a $60B health security portfolio, consisting of six consortia, which has become a cornerstone for addressing federal health security challenges. As a thought leader and ecosystem builder, Dr. Stebbins has engaged stakeholders across the medical and health security and other industrial base sectors over his career through keynote speaking, panel discussions and moderating events. He is committed to fostering organizational development and cultivating a growth mindset within teams to tackle the most pressing national security challenges. Dr. Stebbins also played a key role in winning and then executing the UI LABS-led Digital Manufacturing and Design Innovation Institute (DMDII, now MxD), one of several Manufacturing Innovation Institutes. Other projects include an effort at Ft. Sumter National Monument to incorporate solar panel technology with hydrogen fuel cells to create an energy production and backup power system and an effort to incorporate landfill gas converted to hydrogen as a fuel to power material handling equipment at BMW’s South Carolina production facility. Finally, Mike was a key participant in ATI’s Copper Touch Surfaces and Copper Air Quality programs -- designed to demonstrate and validate that the introduction of copper reduces levels of harmful microbes. Mike was awarded a Ph.D. in analytical chemistry from the University of Tennessee, Knoxville and a B.S. in chemistry from the College of Charleston.
Sessions
- Securing the Future: Biodefense and Health Security Policy Outlook
- Monday, June 16 • 10:00 AM - 10:30 AM